We describe an ELISA for serum lgG antibodies against malondialdetiyde-modifledlow-density lipoprotein(mLDL). Optimal antigen concentration,serum dilution,and dilution of enzyme-conjugated second antibody were 25 mg/L, 1:250, and 1:5000, respectively, when 5 gIL human serum albuminwas used for blocking.When data were expressed as mLDL/LDL (the ratio of lgG binding to mLDL vs LDL), within-run and between-run CVs were 7.0 % and 8.9%, respectively.Antibody concentrationsexpressed as mLDL/ LOL or as mLDL-LDL (the difference between lgG binding to mWL and to LDL) were higher in women with systemic lupus erythematosus (n = 20) than in controls (n = 20) (P <0.001). With bovine serum albumin or Superblock blockingbuffers,onlythe mLDL- LOL data w...
Lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies are the classical tests used to diagno...
Lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies are the classical tests used to diagno...
Increasing evidence indicates that low density lipoprotein (LDL) has to be modified to induce foam c...
Background: Oxidative modification of low-density lipoprotein (LDL) plays a key role in the pathogen...
A significant risk factor for the development of heart disease appears to be oxidized low-density li...
[[abstract]]Human plasma low density lipoproteins (LDL) are composed of approximately 25% apoprotein...
Summary: The potential importance of the non^enzymatic glycation of low density lipoproteins (LDL) i...
Summary Modification of low density lipoprotein (LDL) particles due to oxidation, glycation and bind...
AIM Oxidized phospholipids (OxPL) are the major pathogenic component of oxidized low-density lipo...
[[abstract]]Four monoclonal antibodies (IgG2b) to human plasma low-density lipoproteins (LDL) have b...
The involvement of oxidatively modified low density lipoprotein (LDL) in the development of CHD is w...
Biotecnologia Aplicada 1997;14:253-255 Use of a monoclonal antibody to detect apolipoprotein b in cu...
Low-density lipoprotein (LDL) is a cardiac biomarker identified in the pathology of cardiovascular d...
Inflammation caused by the accumulation of oxidized low-density lipoprotein (oxLDL) in the arterial ...
OBJECTIVES: To develop an enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody (ma...
Lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies are the classical tests used to diagno...
Lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies are the classical tests used to diagno...
Increasing evidence indicates that low density lipoprotein (LDL) has to be modified to induce foam c...
Background: Oxidative modification of low-density lipoprotein (LDL) plays a key role in the pathogen...
A significant risk factor for the development of heart disease appears to be oxidized low-density li...
[[abstract]]Human plasma low density lipoproteins (LDL) are composed of approximately 25% apoprotein...
Summary: The potential importance of the non^enzymatic glycation of low density lipoproteins (LDL) i...
Summary Modification of low density lipoprotein (LDL) particles due to oxidation, glycation and bind...
AIM Oxidized phospholipids (OxPL) are the major pathogenic component of oxidized low-density lipo...
[[abstract]]Four monoclonal antibodies (IgG2b) to human plasma low-density lipoproteins (LDL) have b...
The involvement of oxidatively modified low density lipoprotein (LDL) in the development of CHD is w...
Biotecnologia Aplicada 1997;14:253-255 Use of a monoclonal antibody to detect apolipoprotein b in cu...
Low-density lipoprotein (LDL) is a cardiac biomarker identified in the pathology of cardiovascular d...
Inflammation caused by the accumulation of oxidized low-density lipoprotein (oxLDL) in the arterial ...
OBJECTIVES: To develop an enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody (ma...
Lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies are the classical tests used to diagno...
Lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies are the classical tests used to diagno...
Increasing evidence indicates that low density lipoprotein (LDL) has to be modified to induce foam c...